WHO Adds First Molecular Diagnostic Test for Bundibugyo Virus to Emergency Use Listing
The World Health Organization (WHO) has added the first molecular diagnostic test for Bundibugyo virus (BDBV) to its Emergency Use Listing (EUL).
The test detects the virus by identifying its genetic material in blood samples, helping confirm infection rapidly and accurately.
The WHO’s EUL procedure assesses the quality, safety and performance of essential health products based on available evidence, ensuring they meet minimum international standards and address the needs of low- and middle-income countries.
This listing comes at a critical time as countries respond to the largest recorded outbreak of Ebola disease caused by BDBV.
